For: | Jayasekera D, Hartmann P. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. World J Hepatol 2023; 15(5): 609-640 [PMID: 37305367 DOI: 10.4254/wjh.v15.i5.609] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i5/609.htm |
Number | Citing Articles |
1 |
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, Phillipp Hartmann, Shilpa Sood, Sara Hassan, Charina M Ramirez, Rohit Kohli, Marisa Censani, Erin Mauney, Suzanne Cuda, Sara Karjoo. Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025. Obesity Pillars 2025; 14: 100164 doi: 10.1016/j.obpill.2025.100164
|
2 |
Maria Oana Săsăran, Carmen Muntean, Ancuța Lupu, Vasile Valeriu Lupu. Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver disease. Frontiers in Cell and Developmental Biology 2024; 11 doi: 10.3389/fcell.2023.1336033
|
3 |
Sunitha Vimalesvaran, Pietro Vajro, Anil Dhawan. Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives. Hepatology International 2024; 18(S2): 873 doi: 10.1007/s12072-024-10691-5
|
4 |
Helaina E. Huneault, Jaclyn S. Lo, Shasha Bai, Zhulin He, Michael J. McPhaul, Fernando Bril, Miriam B. Vos, Melanie G. Cree. Fasting intact insulin by mass spectrometry is associated with metabolic dysfunction–associated steatotic liver disease in youth. Hepatology Communications 2024; 8(12) doi: 10.1097/HC9.0000000000000582
|
5 |
Shumin Zhan, Xingyun Wang, Chen Wang, Bowen Zhu, Jianfang Gao, Zhou Peng, Rui Wang, Yun Yang, Liang Zhang, Tengfei Wang, Jiaoxiang Wu, Wei Wu, Ke Huang, Guanping Dong, Qiannan Ren, Shan Wang, Senjie Wang, Xuelian Zhou, Liling Xu, Junfen Fu, Xirong Guo. Tryptophan derivatives as non‐invasive diagnostic indicators for obesity‐related MASLD in children and adolescents. Diabetes, Obesity and Metabolism 2025; doi: 10.1111/dom.70162
|
6 |
Greta Viebahn, Phillipp Hartmann, Sonja Lang, Münevver Demir, Xinlian Zhang, Derrick E. Fouts, Peter Stärkel, Bernd Schnabl. Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2307586
|
7 |
Phillipp Hartmann, Marialena Mouzaki, Sara Hassan, Mohit Kehar, Krupa R. Mysore, Erin Mauney, Dieudonne Nonga, Sara Karjoo, Shilpa Sood, Andrea Tou, Christine Brichta, Rachel E. Herdes, Nikhil Pai, Donna K. Garner, Mary E. Rinella, Mazen Noureddin, Zobair Younossi, Alina M. Allen, Arun Sanyal, Taisa Kohut, Rohit Kohli, Charina M. Ramirez, Stavra Xanthakos, Miriam B. Vos, Jeffrey B. Schwimmer, Samar H. Ibrahim, Jennifer Panganiban. Call to action—Pediatric MASLD requires immediate attention to curb health crisis. Hepatology 2025; doi: 10.1097/HEP.0000000000001440
|
8 |
Дмитрий Олегович Иванов, Дмитрий Владимирович Захаров, Валерия Павловна Новикова, Нина Гивиевна Корбесова, Заурбек Хазбиевич Гулунов, Борис Давидович Старостин.
Метаболически ассоциированная жировая болезнь печени у детей: современное состояние и перспективы на будущее
. Children's medicine of the North-West 2025; 13(2): 84 doi: 10.56871/CmN-W.2025.62.70.007
|
9 |
Claudia Mandato, Pietro Vajro. Serum alanine aminotransferase: Are we still far from a one‐size‐fits‐all pediatric reference cutoff strategy?. Journal of Pediatric Gastroenterology and Nutrition 2024; 78(3): 453 doi: 10.1002/jpn3.12037
|
10 |
M. Yu. Komissarova, R. S. Maltsev, A. M. Filin, M. M. Alimov, N. V. Evdokimova, V. P. Novikova. Metabolic-associated fatty liver disease in children: a modern view of the pathogenesis, clinical features, methods of diagnosis and treatment. Experimental and Clinical Gastroenterology 2025; (9): 75 doi: 10.31146/1682-8658-ecg-229-9-75-85
|